Projected Income Statement: Argan

Forecast Balance Sheet: Argan

Forecast Balance Sheet - Argan
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 1,696 1,877 1,957 1,700 1,693 1,885 1,884 1,915
Change - 10.67% 4.26% -13.13% -0.41% 11.33% -0.05% 1.65%
Announcement Date 1/19/22 1/19/23 1/18/24 1/16/25 1/22/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Argan

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 - - 172.5 111.4 63.85 222 173 174
Change - - - -35.4% -42.68% 247.68% -22.07% 0.58%
Free Cash Flow (FCF) 1 103.2 -110.4 25.09 138.9 124 -14.8 162 131
Change - -206.91% 122.73% 453.56% -10.71% -111.93% 1,194.59% -19.14%
Announcement Date 1/19/22 1/19/23 1/18/24 1/16/25 1/22/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Argan

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 79.26% 76.05% 77.98% 77.7% 94.29% 94.09% 95.02% 95.36%
EBIT Margin (%) 79.2% 59.02% -91.16% 126.44% 137.22% 105.37% 105.23% 105.08%
EBT Margin (%) - - -111.83% 106.44% 116.7% 69.58% 77.12% 81.42%
Net margin (%) 359.91% 48.05% -119.39% 102.8% 115.66% 85.28% 79.59% 78.45%
FCF margin (%) 55.62% -55.77% 11.37% 58.12% 58.5% -6.68% 69.52% 54.1%
FCF / Net Income (%) 15.45% -116.06% -9.52% 56.53% 50.58% -7.84% 87.35% 68.96%

Profitability

        
ROA 16.93% 2.13% 2.95% 3.28% 3.59% 3.6% 3.5% 3.5%
ROE 6.22% 4.38% 6.12% 6.65% 6.68% 7.44% 7.09% 6.93%

Financial Health

        
Leverage (Debt/EBITDA) 11.53x 12.47x 11.37x 9.15x 8.47x 9.05x 8.51x 8.29x
Debt / Free cash flow 16.43x -17.01x 77.99x 12.24x 13.65x -127.33x 11.63x 14.62x

Capital Intensity

        
CAPEX / Current Assets (%) - - 78.14% 46.61% 30.12% 100.26% 74.24% 71.85%
CAPEX / EBITDA (%) - - 100.2% 59.99% 31.94% 106.56% 78.13% 75.35%
CAPEX / FCF (%) - - 687.25% 80.2% 51.48% -1,500% 106.79% 132.82%

Items per share

        
Cash flow per share 1 - - 8.089 - 7.763 7.806 8.003 8.159
Change - - - - - 0.55% 2.52% 1.96%
Dividend per Share 1 2.6 3 3.15 3.3 3.45 3.574 3.687 3.788
Change - 15.38% 5% 4.76% 4.55% 3.59% 3.15% 2.76%
Book Value Per Share 1 - - 81.8 87.6 93.6 91.83 96.71 98.84
Change - - - 7.09% 6.85% -1.9% 5.32% 2.2%
EPS 1 29.7 4.2 -11.4 10 9.6 7.07 6.951 7.441
Change - -85.86% -371.43% 187.72% -4% -26.35% -1.68% 7.05%
Nbr of stocks (in thousands) 22,587 22,940 23,059 25,392 25,721 25,751 25,751 25,751
Announcement Date 1/19/22 1/19/23 1/18/24 1/16/25 1/22/26 - - -
1EUR
Estimates
2026 *2027 *
P/E 9.59x 9.75x
PBR 0.74x 0.7x
EV / Sales 16.4x 15.6x
Yield 5.27% 5.44%

EPS & Dividend

EPS & Dividend - Argan


Y-o-Y evolution of P/E

Valuation ratios - P/E - Argan
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Argan
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Argan
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
67.80EUR
Average target price
77.37EUR
Spread / Average Target
+14.11%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Argan